Key points are not available for this paper at this time.
co-administration of XAV-939 markedly attenuated these therapeutic benefits. Our findings establish that PEMF ameliorates osteoporosis by acting as a physical activator of the Wnt/β-catenin pathway in BMSCs, thereby rectifying their differentiation bias, and present a novel mechanism-based non-invasive strategy.
Wei et al. (Mon,) studied this question.